Introduction
Tuberculosis (TB), the leading cause of death in people living
with human immunodeficiency virus (HIV), is a current global
health challenge.1
Expanding use of antiretroviral therapy has
decreased acquired immune deficiency syndrome (AIDS)-
related deaths in both developing and developed countries.2–5
Nevertheless, TB consistently causes a large number of deaths
among people living with HIV globally, especially in highburden
settings, such as southeast Asia and Africa.6–9 Death
review studies to find out the distribution of causes of death
in TB-HIV coinfected patients are necessary to devise specific
preventive interventions in each high-burden setting